Positive regulation of myeloid leukocyte mediated immunity

pathway activity — cross-omics
GO:0002888Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Positive regulation of myeloid leukocyte mediated immunity pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MEFV, CEP68, and CSF3R, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Positive regulation of myeloid leukocyte mediated immunity activity versus MEFV in LSCC (Pearson r = 0.32).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCMEFV →+0.600+0.148.002.00137
CCRCCCEP68 →-0.352-0.264.002<.00137
UCECCSF3R →+0.936+0.191<.001.00337
BRCAKLHDC2 →-0.485-0.266<.001<.00137
GBMLILRB3 →+0.977+0.430<.001.00237
GBMADGRE2 →+0.745+0.324<.001.00637
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002888 vs MEFV — LSCC

Per-sample scatter of Positive regulation of myeloid leukocyte mediated immunity activity vs MEFV in LSCC.

Explore this scatter interactively →

Exploration